drugset / Press release
MacroGenics Initiates Phase I Clinical Trial of MGAH22 for Patients with HER2-Expressing Solid Tumors
2011-01-06 · MacroGenics · original macrogenics.com ↗
MacroGenics Initiates Phase I Clinical Trial of MGAH22 for Patients with HER2-Expressing Solid Tumors 65.5 KB
The release as fetched from its publisher. macrogenics.com ↗